跳轉至內容
Merck
  • Effects of a metabolic syndrome induced by a fructose-rich diet on bone metabolism in rats.

Effects of a metabolic syndrome induced by a fructose-rich diet on bone metabolism in rats.

Metabolism: clinical and experimental (2013-12-21)
Juan Ignacio Felice, María Virginia Gangoiti, María Silvina Molinuevo, Antonio Desmond McCarthy, Ana María Cortizo
摘要

The aims of this study were: first, to evaluate the possible effects of a fructose rich diet (FRD)-induced metabolic syndrome (MS) on different aspects of long bone histomorphometry in young male rats; second, to investigate the effects of this diet on bone tissue regeneration; and third, to correlate these morphometric alterations with changes in the osteogenic/adipogenic potential and expression of specific transcription factors, of marrow stromal cells (MSC) isolated from rats with fructose-induced MS. MS was induced in rats by treatment with a FRD for 28 days. Halfway through treatment, a parietal wound was made and bone healing was evaluated 14 days later. After treatments, histomorphometric analysis was performed in dissected femoral and parietal bones. MSC were isolated from the femora of control or fructose-treated rats and differentiated either to osteoblasts (evaluated by type 1 collagen, Alkaline phosphatase and extracellular nodule mineralization) or to adipocytes (evaluated by intracellular triglyceride accumulation). Expression of Runx2 and PPARγ was assessed by Western blot. Fructose-induced MS induced deleterious effects on femoral metaphysis microarchitecture and impaired bone regeneration. Fructose treatment decreased the osteogenic potential of MSC and Runx2 expression. In addition, it increased the adipogenic commitment of MSC and PPARγ expression. Fructose-induced MS is associated with deleterious effects on bone microarchitecture and with a decrease in bone repair. These alterations could be due to a deviation in the adipogenic/osteogenic commitment of MSC, probably by modulation of the Runx2/PPARγ ratio.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, lyophilized powder, ≥10 DEA units/mg solid
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, BioUltra, ≥5,700 DEA units/mg protein
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, buffered aqueous solution, ≥2,000 DEA units/mg protein
Sigma-Aldrich
碱性磷酸酶 来源于大肠杆菌, lyophilized powder, 30-60 units/mg protein (in glycine buffer)
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, buffered aqueous glycerol solution, ≥4,000 DEA units/mg protein
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, ≥5,500 DEA units/mg protein
Sigma-Aldrich
磷酸酶(碱性) 来源于小牛肠粘膜, suitable for enzyme immunoassay, solution (clear, colorless), ~2500 U/mg protein (~10 mg/ml)
Sigma-Aldrich
碱性磷酸酶 来源于猪肾脏, lyophilized powder, ≥100 DEA units/mg protein
Sigma-Aldrich
碱性磷酸酶 来源于大肠杆菌, ammonium sulfate suspension, 30-90 units/mg protein (modified Warburg-Christian, in glycine buffer)
Sigma-Aldrich
碱性磷酸酶 来源于大肠杆菌, buffered aqueous glycerol solution, 20-50 units/mg protein (in glycine buffer)
Sigma-Aldrich
磷酸酶,碱性虾, ≥900 DEA units/mL, buffered aqueous glycerol solution, recombinant, expressed in proprietary host
Sigma-Aldrich
磷酸酶(碱性) 牛, recombinant, expressed in Pichia pastoris, ≥4000 units/mg protein
Sigma-Aldrich
磷酸酶(碱性) 来源于人类胎盘, ≥10 units/mg solid (in glycine buffer)